Literature DB >> 22819248

Ovarian endometrioma but not deep infiltrating endometriosis is associated with increased serum levels of interleukin-8 and interleukin-6.

Francisco Carmona1, Charles Chapron, María-Ángeles Martínez-Zamora, Pietro Santulli, Aintzane Rabanal, Mario Martínez-Florensa, Francisco Lozano, Juan Balasch.   

Abstract

Cytokines, and specifically interleukin 6 (IL-6) and interleukin 8 (IL-8), have been associated with the pathogenesis of endometriosis. We studied serum concentrations of IL-6 and IL-8 in patients with deep infiltrating endometriosis (DIE) or ovarian endometriomas (OE), but no other forms of associated endometriosis disease type. We carried out a case-control study including 19 patients with OE alone (OE group), 14 patients with DIE alone (DIE group) and 24 healthy patients without endometriosis (C group). Serum concentrations of IL-6 and IL-8 were measured in the three groups of patients. Serum levels of both IL-6 and IL-8 were significantly higher in the OE group. A high positive correlation was found between serum IL-6 and IL-8 levels in the OE group but not in the DIE and C groups. Serum IL-8 alone achieved the highest predictive value of the presence of OE (adjusted OR: 1.44; sensitivity: 78.2%; specificity: 76.2%). The combination of IL-6 and IL-8 levels did not significantly improve the discrimination between subjects with OE and those with DIE over that of IL-8. OE but not DIE are associated with increased serum levels of IL-6 and IL-8, and thus these may become useful tools for discriminating OE alone from DIE.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22819248     DOI: 10.1016/j.jri.2012.06.001

Source DB:  PubMed          Journal:  J Reprod Immunol        ISSN: 0165-0378            Impact factor:   4.054


  8 in total

Review 1.  Endometriosis: where are we and where are we going?

Authors:  Alexis D Greene; Stephanie A Lang; Jessica A Kendziorski; Julie M Sroga-Rios; Thomas J Herzog; Katherine A Burns
Journal:  Reproduction       Date:  2016-05-10       Impact factor: 3.906

2.  Early growth response 1 transcription factor is essential for the pathogenic properties of human endometriotic epithelial cells.

Authors:  Vineet K Maurya; Maria M Szwarc; Rodrigo Fernandez-Valdivia; David M Lonard; Song Yong; Niraj Joshi; Asgerally T Fazleabas; John P Lydon
Journal:  Reproduction       Date:  2022-06-27       Impact factor: 3.923

Review 3.  Blood biomarkers for the non-invasive diagnosis of endometriosis.

Authors:  Vicki Nisenblat; Patrick M M Bossuyt; Rabia Shaikh; Cindy Farquhar; Vanessa Jordan; Carola S Scheffers; Ben Willem J Mol; Neil Johnson; M Louise Hull
Journal:  Cochrane Database Syst Rev       Date:  2016-05-01

4.  Pro-inflammatory cytokines for evaluation of inflammatory status in endometriosis.

Authors:  Andrei M Malutan; Tudor Drugan; Nicolae Costin; Razvan Ciortea; Carmen Bucuri; Maria P Rada; Dan Mihu
Journal:  Cent Eur J Immunol       Date:  2015-04-22       Impact factor: 2.085

5.  Peritoneal Fluid Cytokines Reveal New Insights of Endometriosis Subphenotypes.

Authors:  Jieliang Zhou; Bernard Su Min Chern; Peter Barton-Smith; Jessie Wai Leng Phoon; Tse Yeun Tan; Veronique Viardot-Foucault; Chee Wai Ku; Heng Hao Tan; Jerry Kok Yen Chan; Yie Hou Lee
Journal:  Int J Mol Sci       Date:  2020-05-15       Impact factor: 5.923

6.  Interplay between Misplaced Müllerian-Derived Stem Cells and Peritoneal Immune Dysregulation in the Pathogenesis of Endometriosis.

Authors:  Antonio Simone Laganà; Emanuele Sturlese; Giovanni Retto; Vincenza Sofo; Onofrio Triolo
Journal:  Obstet Gynecol Int       Date:  2013-06-13

7.  Aberrant expression and hormonal regulation of Galectin-3 in endometriosis women with infertility.

Authors:  H Yang; J Yin; K Ficarrotta; S H Hsu; W Zhang; C Cheng
Journal:  J Endocrinol Invest       Date:  2016-02-17       Impact factor: 4.256

8.  Interleukin-6 (IL-6) Activates the NOTCH1 Signaling Pathway Through E-Proteins in Endometriotic Lesions.

Authors:  Yong Song; Ren-Wei Su; Niraj R Joshi; Tae Hoon Kim; Bruce A Lessey; Jae-Wook Jeong; Asgerally T Fazleabas
Journal:  J Clin Endocrinol Metab       Date:  2020-05-01       Impact factor: 5.958

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.